Literature DB >> 21063105

Endothelial progenitor cells derived from CD34+ cells form cooperative vascular networks.

Sufen Guo1, Yongxia Cheng, Ying Ma, Xianghong Yang.   

Abstract

Studies were conducted to investigate whether endothelial progenitor cells (EPCs) derived from CD34(+) cells could differentiate to endothelial- and smooth muscle-like cells, respectively. Differentiation was induced by either basic fibroblast growth factor (bFGF) or platelet-derived growth factor-BB (PDGF-BB). Further, the contribution of these cells to cooperative blood vessel formation was examined. Immunofluorescence microscopy and Western blot analysis were used to assess vascular smooth muscle (SMC) or endothelial (EC) cell differentiation. SMC (α-SM actin and calponin) or EC (CD31 and von Willebrand factor, vWF) markers showed significant expression. In contrast, expression of the stem/progenitor cell marker CD133 gradually decreased. To quantify the percentage of positive cells of smooth muscle cell marker and endothelial cell marker, flow cytometric analysis was performed, and the results demonstrated that up to 83.76% of PDGF-BB treated-cells were positive for α-SMA marker and up to 89.27% of bFGF-treated cells were positive for vWF marker. To assess functional properties of the endothelial- and smooth muscle-like cells and to demonstrate an association of the two cell types in vascular structures, we evaluated the capacity of these cells to form angiogenesis-like networks on Matrigel. Both endothelial-like cells plated in isolation and co-cultured with smooth muscle-like cells showed formation of vascular networks on Matrigel while smooth muscle-like cells alone did not. Co-culture of fluorescently labeled endothelial- (PKH26, red fluorochrome) and smooth muscle-like cells (PKH67, green fluorochrome) revealed that these cells formed cooperative networks of tubular structures on Matrigel. Collectively, our findings suggest that EPCs can differentiate into both smooth muscle- and endothelial-like cells and contribute to the development of cooperative vascular networks. Notably, this differentiation could also provide a stable foundation for maintenance of the newly formed vascular networks.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21063105     DOI: 10.1159/000322335

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  10 in total

1.  Smooth muscle-like cells resident in the media participate in spasm-induced coronary intimal hyperplasia.

Authors:  Nobuyuki Hiruta; Yuko Maezawa; Yasuto Uchida; Yoshiro Maezawa; Yasumi Uchida
Journal:  Exp Clin Cardiol       Date:  2013

Review 2.  Basement membrane matrix (BME) has multiple uses with stem cells.

Authors:  Irina Arnaoutova; Jay George; Hynda K Kleinman; Gabriel Benton
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

3.  Measurements of CD34+/CD45-dim Stem Cells Predict Healing of Diabetic Neuropathic Wounds.

Authors:  Stephen R Thom; Michelle Hampton; Michael A Troiano; Ziad Mirza; D Scot Malay; Steven Shannon; Nathan B Jennato; Cornelius M Donohue; Ole Hoffstad; Diana Woltereck; Ming Yang; Kevin Yu; Veena M Bhopale; Svitlana Kovtun; David J Margolis
Journal:  Diabetes       Date:  2015-10-20       Impact factor: 9.461

4.  Selective Expansion of CD34+ Cells from Mouse Bone Marrow Cultured on LH/P MP-Coated Plates with Adequate Cytokines.

Authors:  Satoko Kishimoto; Masayuki Ishihara; Yasuhiro Kanatani; Masaki Nambu; Megumi Takikawa; Yuki Sumi; Shingo Nakamura; Yasutaka Mori; Hidemi Hattori; Yoshihiro Tanaka; Toshinori Sato
Journal:  J Tissue Eng       Date:  2011-10-30       Impact factor: 7.813

Review 5.  From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular Remodeling.

Authors:  Rebecca L Heise; Patrick A Link; Laszlo Farkas
Journal:  Front Pediatr       Date:  2016-08-17       Impact factor: 3.418

6.  Multifactorial Optimizations for Directing Endothelial Fate from Stem Cells.

Authors:  Drew E Glaser; William S Turner; Nicole Madfis; Lian Wong; Jose Zamora; Nicholas White; Samuel Reyes; Andrew B Burns; Ajay Gopinathan; Kara E McCloskey
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

7.  VEGF secreted by mesenchymal stem cells mediates the differentiation of endothelial progenitor cells into endothelial cells via paracrine mechanisms.

Authors:  Quanhu Ge; Hongwei Zhang; Jixue Hou; Longfei Wan; Wenzhe Cheng; Xiaoyi Wang; Dan Dong; Congzhe Chen; Jie Xia; Jun Guo; Xueling Chen; Xiangwei Wu
Journal:  Mol Med Rep       Date:  2017-11-14       Impact factor: 2.952

8.  Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells.

Authors:  Joseph C Poole; Arshed A Quyyumi
Journal:  Stem Cells Int       Date:  2013-04-28       Impact factor: 5.443

9.  Avemar and Echinacea extracts enhance mobilization and homing of CD34(+) stem cells in rats with acute myocardial infarction.

Authors:  Maha Abdelmonem; Samar H Kassem; Hala Gabr; Amira A Shaheen; Tarek Aboushousha
Journal:  Stem Cell Res Ther       Date:  2015-09-14       Impact factor: 6.832

10.  Linc-OIP5 in the breast cancer cells regulates angiogenesis of human umbilical vein endothelial cells through YAP1/Notch/NRP1 signaling circuit at a tumor microenvironment.

Authors:  Qing Zhu; Jingchao Li; Qi Wu; Yongxia Cheng; Huizhe Zheng; Tao Zhan; Hongwei Wang; Yue Yang; Hongyan Wang; Ye Liu; Sufen Guo
Journal:  Biol Res       Date:  2020-02-11       Impact factor: 5.612

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.